TIP811: OTC Markets (OTCM): A Picks and Shovels Play in Modern Capital Markets w/ Kyle Grieve & Shawn O'Malley

Summary of TIP811: OTC Markets (OTCM): A Picks and Shovels Play in Modern Capital Markets w/ Kyle Grieve & Shawn O'Malley

by The Investor's Podcast Network

1h 21mApril 30, 2026

Overview of TIP811: OTC Markets (OTCM) — A Picks-and-Shovels Play in Modern Capital Markets

This episode breaks down OTC Markets Group (OTCM), a small but highly important piece of market infrastructure that helps facilitate trading, listings, and data services for thousands of securities outside the NYSE and Nasdaq. The hosts argue that OTCM is a classic “picks and shovels” business: it profits from the growth and activity of capital markets without needing to predict which companies will win. They highlight its strong margins, recurring revenue, pricing power, and long-term compounding, while also flagging the biggest risk: regulatory change could materially weaken its moat.

What OTC Markets Does

OTC Markets operates through three core segments:

1. OTC Link

  • Trading infrastructure and alternative trading system (ATS) for OTC securities.
  • Collects fees from broker-dealers for:
    • subscriptions/connectivity
    • quote publishing
    • trade messaging
    • transaction execution and reporting
  • Acts like a toll bridge: whenever a trade happens through the OTC ecosystem, OTCM gets paid.

2. Corporate Services

  • Helps companies list and maintain quotation on OTC tiers without the cost and complexity of a NYSE/Nasdaq listing.
  • Provides:
    • listing tiers
    • disclosure/compliance support
    • eligibility and legal trading status services
  • Revenue is more subscription-like and less sensitive to trading volume.

3. Market Data Licensing

  • Monetizes the data generated from OTC trading and issuer disclosures.
  • Sells data feeds to:
    • broker-dealers
    • trading firms
    • redistributors like Bloomberg/Refinitiv
    • compliance teams
  • This is the most attractive growing segment because it is more recurring and sticky.

Key Financial Highlights

OTCM has posted impressive long-term compounding:

  • Revenue CAGR (10 years): ~11%
  • Profit CAGR: ~13%
  • Free cash flow CAGR: ~14%
  • Debt: zero since 2016
  • Shares outstanding: basically flat over the decade
  • Gross margin: ~60%
  • Operating margin: ~34%

The hosts emphasize that this is especially notable because the company has grown without meaningful dilution or leverage.

Why the Business Is Attractive

A quasi-monopoly in a niche market

  • OTCM is often the default venue for companies that cannot or do not want to list on major exchanges.
  • NYSE and Nasdaq have stricter listing requirements, which helps preserve OTCM’s niche.
  • For many small or foreign companies, OTCM is the practical alternative.

Strong pricing power

  • OTCM has raised fees over time, especially in corporate services.
  • OTCQX annual fees rose from about $15,000 pre-2017 to about $23,000 in 2021, with further annual increases.
  • Market data pricing has also increased, and a 2025 price hike helped drive segment growth.

High customer retention

  • OTCQB renewal rates are around 90%
  • OTCQX retention is around 95%
  • Corporate services customers tend to stay for many years, creating excellent lifetime value

Operating leverage

  • OTCM has only about 130 employees.
  • Revenue per employee has climbed materially as the business has scaled.
  • The company can grow revenue faster than costs because the platform is light on physical assets and heavy on software, data, and relationships.

Competitive Advantages / Moat

The hosts identify several moat sources:

1. Regulatory barrier / cornered resource

  • OTCM has deep integration with SEC and FINRA processes.
  • That regulatory acceptance is hard to replicate.
  • This is the company’s most important advantage.

2. Network effects

  • More securities and more trading create more data.
  • More data improves the value of OTCM’s data products.
  • More issuers and subscribers reinforce the ecosystem.

3. Switching costs

  • Broker-dealers embed OTCLink into workflows and compliance systems.
  • Issuers risk losing visibility and investor relations infrastructure if they leave.

4. Data moat

  • OTCM’s proprietary data becomes more valuable as its coverage expands.
  • This supports the licensing business and increases stickiness.

Major Risks

1. Regulatory risk is the biggest threat

The hosts repeatedly stress that if regulators change the rules, OTCM could be hurt badly. Examples include:

  • allowing NYSE/Nasdaq to list non-SEC-registered companies
  • creating a separate venture-style exchange framework in the U.S.
  • requiring firms now using OTC tiers to re-register elsewhere

2. Competition from larger platforms

  • NYSE and Nasdaq have bigger brands and deeper liquidity.
  • Bloomberg and Refinitiv have large data businesses, though they are more partners/customers than direct substitutes.
  • Overnight/extended-hours trading could become more competitive if larger exchanges expand offerings.

3. Customer concentration / shrinking subscribers

  • OTC Link subscriber count has fallen over time.
  • A smaller broker-dealer ecosystem can pressure transaction-related revenues.
  • Market data licensing also has some concentration risk, though the segment remains diversified overall.

4. Cyclicality

  • OTCM benefits strongly in bull markets and during speculative surges.
  • Revenue tied to trading volume can be volatile, even if the business remains profitable in downturns.

Unit Economics and Capital Efficiency

A major theme of the episode is that OTCM is capital light:

  • minimal capex
  • low occupancy costs
  • small headcount
  • low marketing spend
  • customer prepayments create negative working capital

The hosts note that traditional ROIC is not a perfect metric here because OTCM’s invested capital can be near zero or negative. Instead, the company’s economics are better understood as:

  • strong recurring revenue
  • low churn
  • long customer tenure
  • high returns on equity
  • limited reinvestment needs

Dividend and capital return profile

OTCM distributes most of its earnings:

  • dividends are a major use of cash
  • buybacks are modest
  • very little is reinvested back into the business

Management Assessment

Cromwell Coulson

The episode paints OTCM’s long-time CEO as a strong steward:

  • CEO for about 29 years
  • owns a very large stake personally
  • Coulson family ownership is roughly 35% combined
  • compensation is much lower than peers at Nasdaq, ICE, or CBOE
  • transparent about both wins and setbacks

Incentives

Management compensation is tied to:

  • revenue growth
  • operating earnings / EPS
  • long-term shareholder value

The hosts like that the company uses EPS-based incentives, since revenue-only incentives can encourage wasteful spending.

Recent/Notable Growth Drivers

The episode highlights several temporary and structural growth drivers:

  • 2021 market mania boosted trading volume and data usage
  • cannabis listings in 2018 helped corporate services
  • SEC rule changes created temporary disclosure-service demand
  • OTC Link Moon ATS launched in 2024 to support overnight trading
  • market data licensing expanded with more professional and retail users

Valuation Takeaway

The hosts build a bullish but not extravagant valuation case:

  • Assumes ~12% annual earnings growth going forward
  • Expects margins to expand modestly over time
  • Projects 2030 net income around $55 million
  • Applies a 25x earnings multiple
  • Implies an estimated value of roughly $113/share
  • Compared with a current price around $54/share, that suggests roughly:
    • ~16% annualized return potential
    • plus a ~4% dividend yield

They note they would prefer to buy OTCM at under 20x earnings to improve margin of safety.

Final Verdict from the Hosts

The hosts view OTCM as:

  • a high-quality business
  • with strong moat characteristics
  • excellent margins and capital efficiency
  • but with a key uncertainty around regulation

Their stance is cautious optimism:

  • they like the business
  • they respect the regulatory risk
  • they would size it modestly, likely as a small tracker position
  • and become more aggressive if the valuation became more attractive

Bottom Line

OTC Markets is presented as a little-known but strategically important infrastructure business with:

  • recurring revenues
  • pricing power
  • strong operating leverage
  • durable customer relationships

But its future depends heavily on one thing: the regulatory framework that keeps its niche intact. If that remains stable, OTCM could continue to quietly compound for years.